24Sep
Northern District Of Illinois Dismisses Putative Class Action Against Pharmaceutical Company For Failure To Adequately Allege Falsity Or Scienter
On September 18, 2019, Judge Charles P. Kocoras of the United States District Court for the Northern District of Illinois dismissed a putative class action against a pharmaceutical company asserting claims under Section 10(b) of the Securities...
By:
Shearman & Sterling LLP
Related
On January 18, 2021, the Office of Planning (“OP”) introduced its first set of proposed amendments...
Read More >
Timing is everything – acts pre-dating disability not discrimination - The EAT decision in Tesco S...
Read More >
With KPMG in the news for one of the biggest ethical trainwrecks in recent memory (or since the last...
Read More >
The U.S. Court of Appeals for the Tenth Circuit was not persuaded that because marijuana remains ill...
Read More >
Women make up the majority of employees in the healthcare industry. According to the Bureau of Labor...
Read More >
Employer plans will still be able to exclude the value of drug manufacturer coupons from annual out-...
Read More >